Pharmacology Redirect‑class

This redirect is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles Redirect This redirect does not require a rating on Wikipedia's content assessment scale.

• Should Lumiracoxib be included in the template? Cmcnicoll 06:31, 8 June 2007 (UTC)[reply]
  • I assume you're asking because it was removed from several markets. Rofecoxib has an even worse reputation, but just because you can't buy them in your part of the world doesn't make them any less NSAIDs, and very effective ones at that. Lumiracoxib is in use in some countries despite health risks. They are popular NSAIDs because of their reputation and because they were developed by major companies. Patients and doctors investigating COX-2 inhibitors are likely to look for information on these two drugs; therefore, their inclusion on this template is quite appropriate. josta59 27 December 2007

Should Propionic acid be created as a subsection within 2-Arylpropionic acids (profens) section?? The other template, Template:Anti-inflammatory and antirheumatic products lists them slightly differently? -- Teutonic Tamer 16:58, 22 February 2008 (UTC)[reply]

Benzydamine, Bumadizone, Difenpiramide, Lonazolac, Morniflumate, Proquazone, Tenidap, Zomepirac, all need adding, but I don't know to which section! -- Teutonic Tamer 17:05, 22 February 2008 (UTC)[reply]

Feprazone - is this a NSAID? If so, it needs adding to the template. -- Teutonic Tamer 10:51, 23 February 2008 (UTC)[reply]

Heh, you should add "anti-inflammatory drugs" to your list of interests, TT! I'm afraid I can't answer any of your questions without doing some research, but I don't have time. josta59 28 February 2008 —Preceding comment was added at 21:41, 28 February 2008 (UTC)[reply]